Shares of Arbutus Biopharma (ABUS) are up 10% in afternoon trading while those of Moderna (MRNA) are now down 3%.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MRNA:
- Moderna rises after Delaware court issues memo in patent fight with Arbutus
- Moderna’s CMV Vaccine Extension Study Reaches Completion, Setting the Stage for Next Growth Catalyst
- SPY ETF Daily Update, 2/2/2026
- SNDK, MU, CRM: January’s Best and Worst-Performing Stocks
- Moderna Stock Slips As Ambitious Cancer Trials Drag On